Cited by 131Medicinal Plants and NeuroprotectionPhytochemicals and Medicinal PlantsNeurological Disorders and Treatments

Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy

G.K., Shinomol, Muralidhara, M.S. Bharath, Muchukunte·2011·Recent Patents on Endocrine, Metabolic & Immune Drug Discovery

Abstract

It has been envisaged that in this century, disorders of the central nervous system will have a significant bearing on the healthcare concerns of the human population worldwide. Such neurological and psychiatric disorders are generally associated with loss of memory, cognitive deficits, impaired mental function etc. Due to the multi-factorial nature of these diseases, modern medicine based psychoactive drugs have met with limited success. Therefore, there is a growing demand for novel products that could target multiple pathways and improve the mental capabilities either independently or in combination with conventional drugs. In the recent times, herbal products based on traditional knowledge have been increasingly used both in developed and developing countries. According to “Ayurveda”, the Indian traditional system of medicine, “medhyarasayanas” represent herbal therapeutics that boost memory, restore cognitive deficits and improve mental function. The current review deals with the components and application of such a traditional herb “Brahmi” that corresponds to two plants, Bacopa monnieri and Centella asiatica. Research evidences clearly indicate that both plants possess neuroprotective properties, have nootropic activity with therapeutic implications for patients with memory loss. The field has witnessed exciting patent activity with most inventions aiming at either (i) improving the methods of herbal extraction or (ii) enrichment and purification of novel compounds from brahmi or (iii) providing novel synergistic formulations for therapeutics in various human ailments. In this review, clinical trials related to the therapeutic properties of brahmi and current patents relevant to the preparation, composition and application have also been included. Keywords: Ayurveda, Bacopa monnieri, brahmi, brain, Centella asiatica, cognitive deficits, learning and memory, nootropic, central nervous system (CNS), pathology, CNS infections, neurological, psychiatric, developmental disorders, neurodegene-rative diseases, human life span, CNS disorders, oxidative stress, mitochondrial damage, protein aggregation, neuro-inflammation, mental deterioration, pharmacotherapy, blood-brain barrier, phytochemicals, drugs, ETHNOPHARMACOLOGY, water hyssop, anxiety, aphrodisiac, diuretic, asthma, respiratory function, alkaloid, D-mannitol, potassium, saponin hersaponin, neurons, anti-oxidant, acetylcholinesterase, neurotoxic properties, neuroprotection, DNA, astrocytes, frontal cortex, cytochrome P450, plasma corticosterone, hippocampus, thiol, epilepsy, amnesic effects, basalis magnocellularis, Acetylcholine concen-trations, Hepatoprotective activity, Cardiovascular Effects, Hypothyroidism, placebo-controlled, neurosis, insomnia, tremors, anti-proliferative, anti-genotoxic, Asiaticoside, Rhamnose, hypothalamus, seizure, antiepileptic drugs, multiple sclerosis, prepubertal, synergistic effect, B-complex, phosphatidyl serine

Integrity signals

Registry

Crossref · 10.2174/187221411794351833

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Various CNS active Indian herbal medicines such as Withania somnifera, Centella asiatica, Celastrus paniculatus and Bacopa monnieri have shown cognitive improvement in experimental models of Alzheimer's disease when given as prophylactic treatment.

    “Various CNS active Indian herbal medicines like Withania somnifera, Centella asiatica, Celastrus paniculatus and Bacopa monnieri have shown cognitive improvement in experimental models of AD when given as prophylactic treatment [43,44,45,46,47,48].”

The citation lists haven’t been fetched yet

References 112 · Cited by 131

Authors
G.K., S., Muralidhara, & M.S. Bharath, M.
Affiliations
2900, Hosur Road, Bangalore-560029, Karnataka, India.
Venue
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Published
2011-01-01
Volume
5
Issue
1
Pages
33-49
ISSN
1872-2148 (ISSN-L)
OpenAlex
W2159430856
Cited by
131
References
112
Citations by year
2026: 4 · 2025: 7 · 2024: 14 · 2023: 16 · 2022: 14 · 2021: 15 · 2020: 11 · 2019: 7 · 2018: 8 · 2017: 8 · 2016: 6 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 5
FWCI
13.57
Type
journal article
Language
en
Open access
closed
Locations
  • Recent Patents on Endocrine Metabolic & Immune Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
Bacopa monnieri, Centella asiatica, Ayurveda, nootropic activity, neuroprotection, memory loss, cognitive impairment, central nervous system disorders, neurodegenerative diseases, neuroinflammation, oxidative stress, acetylcholinesterase inhibition, blood-brain barrier, phytochemicals, herbal formula, patents, clinical trials
MeSH terms
Animals, Brain, Clinical Trials as Topic, Cognition, Humans, Medicine, Ayurvedic, Memory, Memory Disorders, Patents as Topic, Plant Extracts, Plants, Medicinal, Anti-Anxiety Agents, Triterpenes, Molecular Structure, Neuroprotective Agents, Nootropic Agents, Centella, Bacopa

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review